Recombinant Mouse Mitochondrial inner membrane organizing system protein 1 (Minos1)

Shipped with Ice Packs
In Stock

Description

Production and Purity

Recombinant Mouse Minos1 is synthesized using heterologous expression systems, including bacterial, yeast, and mammalian cell hosts. Purity is consistently reported as ≥85% via SDS-PAGE .

Production Parameters

Host SystemPurityApplicationsReferences
E. coli≥85% SDS-PAGEELISA, Western blot, protein-protein assays
Yeast≥85% SDS-PAGEStructural studies, biochemical assays
Mammalian cells≥85% SDS-PAGEFunctional assays, interaction studies

Partial recombinant proteins (e.g., lacking N-terminal regions) are also available for specific applications .

Research Applications

Recombinant Mouse Minos1 is utilized in studies targeting mitochondrial dynamics, protein import, and membrane organization.

Key Research Findings

ApplicationExperimental InsightSource
Cristae MorphologyDepletion of Minos1 disrupts cristae junctions, impairing mitochondrial function .
Protein ImportInteracts with SAM/TOM complexes to facilitate β-barrel protein biogenesis .
MICOS Complex AssemblyForms stable complexes with mitofilin/Fcj1, critical for inner membrane integrity .

Functional Interactions

Recombinant Minos1 enables studies of its interactions with mitochondrial translocases and MICOS subunits:

  1. SAM Complex Interaction:

    • Binds via the SAM50 POTRA domain, stabilizing β-barrel protein import .

  2. TOM Complex Interaction:

    • Mediates interplay with TOM subunits, independent of the POTRA domain .

  3. Mitofilin/Fcj1 Complex:

    • Co-purifies with Fcj1 in high-molecular-weight complexes (>1.2 MDa), essential for cristae junction stability .

Experimental Challenges and Considerations

  • Partial Recombinant Proteins: Truncated versions may lack functional regions, limiting utility in interaction studies .

  • Host-Dependent Modifications: Post-translational modifications (e.g., phosphorylation) in mammalian systems may alter activity compared to bacterial/yeast systems .

Product Specs

Form
Lyophilized powder
Note: We prioritize shipping the format we currently have in stock. However, if you require a specific format, please indicate your preference in the order notes. We will accommodate your request whenever possible.
Lead Time
Delivery times may vary based on the purchase method and location. Please consult your local distributors for specific delivery estimates.
Note: All of our proteins are shipped with standard blue ice packs unless otherwise requested. If you require dry ice shipping, please inform us in advance as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure the contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We suggest adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard final glycerol concentration is 50%. Customers can use this as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer components, temperature, and the protein's intrinsic stability.
Generally, liquid formulations have a shelf life of 6 months at -20°C/-80°C. Lyophilized forms typically have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type is determined during production. If you have a specific tag type in mind, please inform us, and we will prioritize developing the specified tag.
Synonyms
Micos10; Mic10; Minos1; MICOS complex subunit Mic10; Mitochondrial inner membrane organizing system protein 1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-76
Protein Length
full length protein
Species
Mus musculus (Mouse)
Target Names
Minos1
Target Protein Sequence
MSESELGRKWDRCMADTVVKLGTGFGLGIVFSLTFFKRRMWPLAFGSGVGLGMAYSNCQH DFQAPYLLHGKYVKEQ
Uniprot No.

Target Background

Function
Minos1 is a component of the MICOS complex, a large protein complex embedded in the mitochondrial inner membrane. The MICOS complex plays vital roles in maintaining crista junctions, ensuring proper inner membrane architecture, and facilitating the formation of contact sites with the outer membrane.
Database Links
Protein Families
MICOS complex subunit Mic10 family
Subcellular Location
Mitochondrion inner membrane; Single-pass membrane protein.

Q&A

What is MINOS1 and what is its subcellular localization?

MINOS1 (Mitochondrial Inner Membrane Organizing System protein 1) is a conserved mitochondrial protein that forms part of the mitofilin/Fcj1 complex in the inner mitochondrial membrane . Subcellular localization studies using immunofluorescence microscopy reveal that MINOS1 exhibits a primarily mitochondrial localization pattern that overlaps with mitochondrial markers such as cyclophilin D .

At the submitochondrial level, biochemical fractionation analyses demonstrate that MINOS1 is an integral membrane protein of the inner mitochondrial membrane . The protein displays resistance to protease treatment in intact mitochondria but becomes accessible to proteases when the outer membrane is disrupted by osmotic swelling (creating mitoplasts) . This behavior is similar to that of TIM23, indicating that MINOS1 is exposed to the intermembrane space (IMS) . Furthermore, MINOS1 shows resistance to alkaline extraction, confirming its status as an integral membrane protein rather than a peripheral membrane protein .

What is the structural composition of MINOS1?

Primary sequence analyses reveal that MINOS1 contains two predictable transmembrane segments separated by a short stretch of charged residues . Unlike many mitochondrial proteins, MINOS1 lacks an appreciable N-terminal presequence . This structural arrangement is crucial for its function within the mitochondrial inner membrane.

The protein contributes to a larger heterooligomeric complex known as MINOS (Mitochondrial Inner Membrane Organizing System). This complex forms distinct clusters within mitochondria, as revealed by super-resolution stimulated emission depletion (STED) microscopy . The spatial arrangement of these clusters shows a remarkable level of regularity in human mitochondria, supporting MINOS's integrating role in the structural organization of the organelle .

How does MINOS1 contribute to mitochondrial morphology?

MINOS1 plays a central role in maintaining mitochondrial morphology as part of the mitofilin/Fcj1 complex . The MINOS complex is required for keeping cristae membranes attached to the inner boundary membrane via crista junctions and interacts with protein complexes of the mitochondrial outer membrane .

Detailed studies have shown that MINOS1 is preferentially localized at cristae junctions . In primary human fibroblasts, MINOS subunits form regularly spaced patterns of clusters arranged in parallel to the cell growth surfaces . This array of MINOS complexes explains the observed phenomenon of largely horizontally arranged cristae junctions that connect the inner boundary membrane to lamellar cristae .

The importance of MINOS1 in maintaining cristae structure is further highlighted by the fact that disruption of the MINOS complex leads to detachment of cristae membranes from the inner boundary membrane . This demonstrates the protein's essential role in organizing mitochondrial inner membrane architecture.

What experimental approaches are optimal for studying MINOS1 spatial distribution?

Super-resolution microscopy techniques offer significant advantages for visualizing the spatial distribution of MINOS1 within mitochondria. Stimulated emission depletion (STED) microscopy has been successfully employed to reveal that MINOS1 forms distinct clusters within mitochondria . This approach overcomes the diffraction limit of conventional microscopy and allows for nanoscale resolution of protein distributions.

For researchers interested in MINOS1 spatial organization, the following experimental approach is recommended:

  • Immunofluorescence labeling with specific antibodies against MINOS1 and other MINOS components (mitofilin, CHCHD3)

  • STED microscopy imaging to resolve the nanoscale distribution

  • Quantitative analysis of cluster patterns and spatial relationships

  • Comparison between different cell types and mitochondrial regions

This approach has revealed that MINOS is more abundant in mitochondria around the nucleus than in peripheral mitochondria , an observation that would be difficult to make with conventional microscopy techniques.

For even higher resolution studies, immunogold electron microscopy can be employed to determine the precise localization of MINOS1 at the submitochondrial level, particularly its association with cristae junctions .

How do MINOS1 interactions with other proteins influence mitochondrial structure?

MINOS1 functions as part of the larger MINOS complex, which interacts with protein complexes of the mitochondrial outer membrane . These interactions are critical for maintaining proper mitochondrial membrane architecture. Research has shown that the mitofilin component of the MINOS complex contains domains that mediate these interactions, including a transmembrane anchor in the inner membrane and intermembrane space domains (a coiled-coil domain and a conserved C-terminal domain) .

Experimental deletion of the C-terminal domain of mitofilin disrupts the MINOS complex and leads to release of cristae membranes from the inner boundary membrane . Interestingly, this deletion also enhances the interaction of mitofilin with the translocase of the outer membrane (TOM) and the sorting and assembly machinery (SAM) . This suggests that MINOS1, as part of the MINOS complex, participates in a dynamic interplay between inner membrane organization and outer membrane protein complexes.

To study these interactions, researchers should consider:

  • Co-immunoprecipitation experiments to identify direct interaction partners

  • Blue native PAGE to preserve protein complexes

  • Proximity labeling techniques (BioID, APEX) to identify transient interactions

  • Mutation studies targeting specific domains of MINOS1 and other MINOS components

What methodologies can detect changes in cristae morphology following MINOS1 manipulation?

When studying the effects of MINOS1 manipulation on cristae morphology, several complementary approaches should be considered:

Electron Microscopy (EM): This remains the gold standard for visualizing cristae structure at high resolution. Transmission EM of ultrathin sections can reveal detailed changes in the number, size, and orientation of cristae following MINOS1 knockdown or mutation.

Tomographic Reconstruction: Electron tomography allows for 3D reconstruction of mitochondrial membranes, providing a comprehensive view of how MINOS1 manipulation affects the entire cristae network.

Live-Cell Super-Resolution Microscopy: For dynamic studies, super-resolution techniques compatible with live cells can capture real-time changes in cristae morphology.

Quantitative Metrics: Researchers should implement quantitative measures of cristae morphology, including:

ParameterDescriptionAnalysis Method
Cristae DensityNumber of cristae per unit length of mitochondriaCount normalized to mitochondrial length
Cristae Junction DiameterWidth of the connection between cristae and inner boundary membraneDirect measurement from EM images
Cristae WidthThickness of cristae membranesDirect measurement perpendicular to cristae length
Inter-cristae DistanceSpace between adjacent cristaeMeasurement between parallel cristae
Cristae OrientationAngle relative to the long axis of mitochondriaAngular measurement from reference axis

These parameters can be quantitatively compared between wild-type and MINOS1-manipulated samples to objectively assess changes in cristae morphology.

What are the optimal conditions for expressing recombinant mouse MINOS1?

When designing experiments for recombinant mouse MINOS1 expression, researchers should consider the following methodological approach:

Expression System Selection: For mammalian membrane proteins like MINOS1, several expression systems can be considered:

  • Bacterial expression (E. coli):

    • Advantages: Low cost, high yield

    • Challenges: May form inclusion bodies due to lack of proper folding machinery for membrane proteins

    • Recommendation: Use specialized strains (C41, C43) designed for membrane protein expression

  • Yeast expression (S. cerevisiae, P. pastoris):

    • Advantages: Eukaryotic folding machinery, post-translational modifications

    • Recommendation: Suitable for functional studies as yeast contains MINOS1 homologs

  • Insect cell expression (Sf9, High Five):

    • Advantages: Higher eukaryotic system, better for complex membrane proteins

    • Recommendation: Preferred for structural studies requiring high purity

  • Mammalian cell expression (HEK293, CHO):

    • Advantages: Native folding environment, proper post-translational modifications

    • Recommendation: Optimal for functional studies despite lower yields

Construct Design Considerations:

  • Include appropriate purification tags (His6, FLAG, etc.) at the C-terminus to avoid interference with mitochondrial targeting

  • Consider fusion with fluorescent proteins for localization studies

  • For membrane protein purification, include TEV protease cleavage sites to remove tags after purification

Expression Optimization Parameters:

  • Induction temperature: Lower temperatures (16-25°C) often improve folding

  • Induction time: Extend to 16-24 hours for proper folding

  • Media supplements: Add membrane-stabilizing agents (glycerol, specific detergents)

How should researchers design experiments to study MINOS1's role in cristae junction formation?

To effectively study MINOS1's role in cristae junction formation, a comprehensive experimental design should include:

Genetic Manipulation Approaches:

  • CRISPR/Cas9-mediated knockout or knockdown using shRNA/siRNA

  • Rescue experiments with wild-type and mutant MINOS1 variants

  • Domain-specific mutations to identify regions critical for cristae junction formation

Microscopy Analysis:

  • Correlative light and electron microscopy (CLEM) to connect fluorescently labeled MINOS1 with ultrastructural features

  • Immuno-electron microscopy with gold-labeled antibodies against MINOS1

  • Super-resolution microscopy using STED or STORM techniques

Biochemical Characterization:

  • Membrane fractionation to isolate cristae junction-enriched fractions

  • Cross-linking studies to capture transient interactions

  • Blue native PAGE to preserve native protein complexes

Functional Assays:

  • Mitochondrial respiration measurements to correlate structural changes with functional outcomes

  • Membrane potential assessments using potentiometric dyes

  • Calcium handling capacity as cristae structure affects calcium storage

Statistical Considerations:

  • Use randomized block designs for large studies to control for batch effects

  • Determine appropriate replicate numbers through power analysis

  • Include both technical replicates (instrument/sample prep variability) and biological replicates

What analytical techniques can verify proper folding of recombinant MINOS1?

Verifying the proper folding of recombinant MINOS1 is crucial for functional studies. Researchers should employ multiple complementary techniques:

Biophysical Characterization:

  • Circular Dichroism (CD) Spectroscopy: Provides information about secondary structure content (α-helices, β-sheets)

  • Fluorescence Spectroscopy: Intrinsic tryptophan fluorescence can indicate proper tertiary structure

  • Thermal Shift Assays: Well-folded proteins typically show cooperative unfolding transitions

Functional Verification:

  • Liposome Reconstitution: Properly folded MINOS1 should incorporate into artificial membranes and potentially induce membrane curvature changes, similar to how LETM1 (another mitochondrial inner membrane protein) induces invaginated membrane structures in proteoliposomes

  • Binding Assays: Test interactions with known MINOS complex components

Structural Analysis:

  • Limited Proteolysis: Well-folded proteins show resistance to proteolysis except at exposed loops

  • Size-Exclusion Chromatography: Properly folded protein should elute at the expected molecular weight

  • Dynamic Light Scattering: Monitors protein homogeneity and aggregation state

What are common challenges in generating antibodies against MINOS1 and how can they be overcome?

Generating specific antibodies against MINOS1 presents several challenges due to its nature as a membrane protein. Researchers frequently encounter the following issues and should consider these solutions:

Challenge: Limited Antigenicity of Membrane-Spanning Regions

  • Solution: Target antibody generation against hydrophilic loops or termini exposed to the intermembrane space

  • Evidence-based approach: MINOS1 contains charged residues between its two transmembrane segments that may serve as good antigenic determinants

Challenge: Cross-Reactivity with Other MINOS Components

  • Solution: Perform thorough sequence analysis to identify unique epitopes specific to MINOS1

  • Validation: Test antibody specificity against MINOS1-knockout samples

Challenge: Low Immunogenicity

  • Solution: Use carrier proteins (KLH, BSA) conjugated to MINOS1-specific peptides

  • Alternative: Consider generating recombinant antibody fragments (scFv, Fab) through display technologies

Challenge: Conformational Epitope Recognition

  • Solution: Immunize with properly folded recombinant protein rather than peptides

  • Method: Purify MINOS1 in mild detergents that preserve native conformation

Antibody Validation Protocol:

  • Western blot against mitochondrial fractions from multiple species to confirm specificity

  • Immunofluorescence with co-localization studies using established mitochondrial markers

  • Immunoprecipitation followed by mass spectrometry to confirm target identity

  • Testing antibody performance in MINOS1-depleted cells as negative controls

How can researchers address conflicting results in MINOS1 functional studies?

When confronted with conflicting results in MINOS1 functional studies, researchers should implement a systematic troubleshooting approach:

Evaluate Model System Differences:

  • Different cell types may have varying dependencies on MINOS1 for cristae structure

  • Cross-species comparisons should account for evolutionary differences in the MINOS complex

Assess Knockdown/Knockout Efficiency:

  • Incomplete depletion may lead to partial phenotypes

  • Compensatory mechanisms might activate with chronic but not acute depletion

  • Consider inducible systems for temporal control of MINOS1 expression

Examine Experimental Conditions:

  • Mitochondrial morphology is sensitive to stress conditions

  • Standardize cell culture conditions, including:

    • Cell density and passage number

    • Medium composition and serum batch

    • Time of analysis after manipulation

Implement Robust Controls:

  • Include rescue experiments with wildtype MINOS1 to confirm specificity of observed phenotypes

  • Use multiple independent siRNAs/shRNAs to rule out off-target effects

  • Consider CRISPR activation/inhibition as complementary approaches

Statistical Rigor:

  • Ensure sufficient biological replicates (n≥3) with technical replicates

  • Use appropriate statistical tests based on data distribution

  • Consider blinding analysis to prevent unconscious bias

Multi-method Verification:

  • Confirm findings using orthogonal techniques (e.g., both microscopy and biochemical approaches)

  • When possible, validate in multiple cell lines or primary cells

What statistical approaches are most appropriate for analyzing MINOS1 distribution patterns?

Spatial Point Pattern Analysis:

  • Ripley's K-function: Determines whether MINOS1 clusters exhibit random, regular, or clustered distribution

  • Nearest Neighbor Distance (NND): Quantifies the spacing between adjacent MINOS1 clusters

  • Pair Correlation Function: Analyzes the probability of finding clusters at different distances

Cluster Characterization Metrics:

  • Density-Based Spatial Clustering (DBSCAN): Identifies clusters based on density parameters

  • Cluster size distribution: Examines the heterogeneity in cluster dimensions

  • Cluster intensity analysis: Correlates with protein abundance

Colocalization Analysis:

  • Manders' Overlap Coefficient: Quantifies spatial overlap with other mitochondrial markers

  • Pearson's Correlation Coefficient: Measures correlation between intensity distributions

  • Object-based colocalization: Determines the percentage of MINOS1 clusters that overlap with cristae junctions

Statistical Testing and Validation:

  • Bootstrap resampling to establish confidence intervals for spatial statistics

  • Monte Carlo simulations to generate null hypothesis distributions

  • Cross-validation between different imaging fields and biological replicates

These approaches can objectively characterize the observed regular spacing pattern of MINOS1 clusters arranged parallel to cell growth surfaces in human fibroblasts , providing quantitative support for the role of MINOS in organizing cristae junctions.

How can researchers distinguish between direct and indirect effects of MINOS1 manipulation?

Distinguishing between direct consequences of MINOS1 manipulation and secondary effects presents a significant challenge. Researchers should employ the following methodological approaches:

Temporal Analysis:

  • Use time-course experiments after MINOS1 depletion/overexpression to identify primary events

  • Early alterations (hours) are more likely to be direct consequences

  • Later changes (days) may represent compensatory or adaptive responses

Structure-Function Relationship:

  • Create domain-specific mutants of MINOS1 to map functions to specific protein regions

  • Transmembrane domains likely contribute to membrane anchoring and possibly membrane curvature

  • Charged residue segments may mediate protein-protein interactions within the MINOS complex

Proximity-Based Methods:

  • BioID or APEX2 proximity labeling to identify proteins in the immediate vicinity of MINOS1

  • In situ cross-linking to capture direct binding partners

  • Split-GFP complementation to verify direct interactions in living cells

Reconstitution Systems:

  • Liposome reconstitution experiments with purified components to test direct membrane effects

  • Similar to LETM1, MINOS1 might directly induce membrane curvature when reconstituted in liposomes

Multi-omics Integration:

  • Combine proteomics, metabolomics, and functional data to build causality networks

  • Use statistical approaches like partial correlation analysis to distinguish direct from indirect relationships

  • Implement pathway analysis to identify functional consequences of MINOS1 perturbation

Rescue Experiments:

  • Wild-type MINOS1 rescue should reverse direct effects

  • Targeted rescue of downstream pathways can identify mediators of indirect effects

By systematically implementing these approaches, researchers can build a hierarchy of effects following MINOS1 manipulation and distinguish primary structural roles from secondary functional consequences.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.